Intraductal papillary mucinous tumors of the pancreas
- 45 Downloads
Methods. Literature is thoroughly reviewed and compared to our own experience.
Results. Clinical history data do not appear to be useful in differentiating between benign and malignant cases. Usually IPMT patients are older than individuals suffering from chronic obstructive pancreatitis and tend to drink and smoke less. Malignant forms of IPMT are more frequently associated with diabetes, and pain seems to be more frequent in benign cases, although these findings are not confirmed in all reports. Also, laboratory tests are of little use, whereas imaging findings currently enable us to reach a correct diagnosis in about 70% of cases without differentiating in a reliable and definitive way the benign or malignant nature of the neoplasm. The WHO classification appears to be related to the different prognosis. Surgery, whenever possible, is the gold standard treatment.
Conclusion. IPMT are a recent established clinical entity embracing a spectrum of lesions ranging from benign to malignant infiltrating cases. The only recognized radical treatment is surgery. Despite diagnostic capacity based on clinical presentation and imaging techniques has becoming increasingly refined we are still incapable of identifying the different degree of malignancy preoperatively, if any. The lengthy mean survival after resection confirm the high potential cure rate of IPMT of the pancreas.
KeywordsIntraductal Papillary Mucinous Tumor Pancreatology Volume Uncinate Process Main Duct Branch Duct
Unable to display preview. Download preview PDF.
- 1.Ohashi K, Murakami Y, Maruyama M. Four cases of mucinproducing cancer of the pancreas on specific findings of the papilla of Vater. Prog Dig Endosc 1982; 20: 348–351.Google Scholar
- 12.Conley CR, Scheithauer BW, van Heerden JA, Weiland LH, et al. Diffuse intraductal papillary adenocarcinoma of the pancreas. Am Surg 1987; 205: 246–249.Google Scholar
- 17.Sessa F, Solcia E, Capella C, Bonato M, Scarpa A, Zamboni G, et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch 1994; 425: 357–367.PubMedCrossRefGoogle Scholar
- 21.Kloeppel G, Solcia E, Longnecker DS, et al. Histological typing of tumours of the exocrine pancreas, in World Health Organization International Histological Classification of Tumours. Springer Verlag, New York, 1996.Google Scholar
- 28.Onaya H, Itai Y, Niitsu M, Chiba T, Michishita N, Saida Y. Ductectatic mucinous cystic neoplasms of the pancreas: evaluation with mr cholangiopancreatography. Am J Roentgenol 1998; 177: 171–177.Google Scholar
- 42.Matsuda Y, Shimakura K, Shigeo S, et al. A case of mucinproducing pancreatic tumor developed during long term follow-up of chronic pancreatitis with special reference to the changes of pancreatogram. Gastroenterol Endosc 1988; 30: 1271–1277.Google Scholar
- 43.Hruban R, Yeo C, Kern S. Pancreatic cancer, in The Genetic Basis of Human Cancer. Vogelstein B, Kinzler K, eds. McGraw-Hill, London. 1998, pp. 603–613.Google Scholar
- 44.Hruban R, Van Masfeld A, Offerhaus G, van Weering DH, Allison DC, Goodman SN, et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993; 143: 545–554.PubMedGoogle Scholar
- 46.Moakaluk CA, Hruban R, Kern S. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1994; 57: 2140–2143.Google Scholar